| 股票代码 | 300601 | 当期评分 | ||||
| 股票名称 | 康泰生物 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.5269 | 0.7838 | 0.7487 | 0.7487 | 0.7487 | ✘ |
| 销售净利润率(%) | 21.6017 | 29.5629 | 30.509 | 30.509 | 30.509 | ✔ |
| 销售毛利率(%) | 90.5643 | 91.0469 | 92.3423 | 92.3423 | 92.3423 | ✔ |
| 净资产收益率(%) | 23.77 | 20.86 | 6.25 | 6.25 | 6.25 | ✘ |
| 营业增长率(%) | 73.6949 | -3.6477 | 1.8722 | 1.8722 | 1.8722 | ✘ |
| 净利润增长率(%) | 102.9241 | 31.8626 | 0.5773 | 0.5773 | 0.5773 | ✘ |
| 每股收益(%) | 0.7 | 0.91 | 0.6616 | 0.4022 | 0.0038 | ✔ |
| 现金流量比率(%) | 34.545 | 58.1146 | 37.0192 | 3.1597 | -9.6018 | ✘ |
| 三项费用比重(%) | 58.4514 | 49.4383 | 47.9893 | 47.9055 | 68.3497 | ✘ |
| 每股净资产(¥) | 2.8702 | 4.2687 | 10.1613 | 9.6204 | 4.321 | ✔ |
| 流动比率(%) | 1.7866 | 2.1009 | 3.9346 | 5.7227 | 2.2022 | ✔ |
| 速动比率(%) | 1.5853 | 1.8381 | 3.6639 | 5.3594 | 1.8347 | ✔ |
| 现金比率(%) | 65.1533 | 58.0592 | 92.0441 | 89.4687 | 89.4687 | ✔ |
| 总资产利润率(%) | 15.7084 | 15.7639 | 6.9625 | 4.5623 | 0.0618 | ✘ |
| 主营利润比重% | 373.4689 | 266.689 | 260.8692 | 268.2928 | 5116.5135 | ✔ |
| 应收账款(万元) | 85,546.61 | 105,002.19 | 141,121.97 | 133,768.09 | 102,797.58 | ✔ |
| 应收票据(万元) | 229.88 | 70.00 | 141.06 | 18.80 | 116.56 | ✔ |
| 预付款项(万元) | 979.09 | 1,231.39 | 7,640.83 | 4,468.75 | 1,781.49 | ✔ |
| 存货(万元) | 19,608.67 | 22,875.96 | 37,209.61 | 29,885.05 | 28,911.17 | ✔ |
| 在建工程(万元) | 61,560.84 | 46,228.58 | 60,951.92 | 42,476.37 | 47,062.79 | ✔ |
| 应付款项(万元) | 9,170.56 | 11,657.05 | 9,670.49 | 9,663.49 | 11,164.14 | ✔ |
| 长期借款(万元) | 25,501.83 | 19,501.83 | 1,979.55 | -- | 18,001.83 | ✔ |
| 未分配利润(万元) | 61,671.68 | 99,017.51 | 122,175.91 | 124,998.58 | 99,259.93 | ✔ |
| 商誉(万元) | -- | -- | -- | -- | -- | ✔ |
| 流动资产(万元) | 159,621.37 | 212,421.28 | 308,566.92 | 272,945.08 | 215,737.38 | ✘ |
| 流动负债(万元) | 97,402.41 | 87,017.93 | 137,485.94 | 82,261.88 | 78,660.30 | ✔ |
康泰生物300601评分结果 | 63.64分 | 卖出/减持 | ||||